(Q42283167)

19 October 2017

Site-differential gastrointestinal absorption of benazepril hydrochloride in healthy volunteers (English)

1 reference

19 October 2017

1 reference

K K Chan

1

1 reference

19 October 2017

A Buch

2

1 reference

19 October 2017

R D Glazer

3

1 reference

19 October 2017

V A John

4

1 reference

19 October 2017

W H Barr

5

1 reference

19 October 2017

1 March 1994

1 reference

19 October 2017

Pharmaceutical Research

1 reference

19 October 2017

11

1 reference

19 October 2017

3

1 reference

19 October 2017

432-437

1 reference

Pharmacokinetics of the angiotensin converting enzyme inhibitor benazepril.HCl (CGS 14 824 A) in healthy volunteers after single and repeated administration

19 October 2017

1 reference

12 December 2020

Evidence for site-specific absorption of a novel ACE inhibitor

1 reference

12 December 2020

Haemodynamic and pharmacological effects of the converting enzyme inhibitor CGS 14824A in normal volunteers

1 reference

12 December 2020

Effects of first-pass metabolism on metabolite mean residence time determination after oral administration of parent drug

1 reference

12 December 2020

Critical analysis of "flip-flop" phenomenon in two-compartment pharmacokinetic model

1 reference

12 December 2020

Determination of a new angiotensin converting enzyme inhibitor and its active metabolite in plasma and urine by gas chromatography-mass spectrometry

1 reference

12 December 2020

A simple method for obtaining the mean residence time of metabolites in the body

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1018925407109

1 reference

19 October 2017

1 reference